Drugmaker Cipla Ltd’s newly formed consumer healthcare subsidiary Cipla Health Ltd, in which PE firm Eight Roads Ventures has a minority stake, aims to have at least three products with a brand value of more than Rs 100 crore each in the next three years, CEO Anantha Nayak told VCCircle."We ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
